Strongyle egg shedding consistency in horses and factors affecting consistency were investigated. Fecal samples were collected from 26 equine populations over one grazing season. Samples were collected on four "screening" occasions (S1-S4) and fecal egg count (FEC) performed (to 1 egg per gram [epg] egg detection limit). On each screening occasion, FEC was assigned an egg shedding category: 1 (<50 epg) to 7 (>500 epg); and a treatment category: <200 epg (no treatment) or !200 epg (treatment). Rank changes in shedding and treatment categories between S1 and subsequent screening occasions were calculated. Factors affecting the likelihood of an individual changing shedding or treatment category were assessed using multivariable logistic regression of FEC data from horses that had not received anthelmintic during the study. In total, 573 horses were sampled at S1, 468 at S2, 417 at S3, and 83 at S4. Results showed that between S1 and S4, 73.5% (61/83) horses remained in the same egg shedding category and 94.0% (78/83) in the same treatment category. For horses that did not receive anthelmintic (n ¼ 304), 90.4% (225/304) remained in the same shedding category. Horses under 5 years old were more likely to change egg shedding (odds ratio [OR] ¼ 3.3; 95% confidence interval [CI]: 1.22-8.46) and treatment (OR ¼ 2.8; 95% CI: 1.1-6.3) categories compared to older horses. These results suggest a high level of consistency in strongyle egg shedding in individuals within one season, and withholding anthelmintics from horses with negative/low (i.e., <50 epg) FEC does not appear to lead to significant increases in egg shedding.
Introduction
Anthelmintic-resistant nematodes pose a threat to equine health and welfare. Targeting anthelmintic treatments to individual horses based on levels of nematode egg shedding is proposed to achieve control, while reducing anthelmintic use and selection for resistance. Helminth parasites are typically overdispersed in their hosts: that is, relatively few individuals within populations are infected with the majority of the associated parasite population [1] [2] [3] [4] . Strongyle nematodes in the large intestine are the most important equine parasites and have a high prevalence [5] . Overdispersion has been demonstrated for strongyle fecal egg counts (FECs) in horses, with most individuals shedding relatively low numbers of eggs [6] [7] [8] . This overdispersion underpins the rationale behind targeted anthelmintic treatment strategies [5, 9, 10] , whereby only horses identified as shedding above a specific threshold of eggs (typically !200 eggs per gram [epg] ) are recommended for treatment. Several studies have shown consistency in strongyle egg shedding patterns in individuals over time [7, [11] [12] [13] [14] , which could further enhance efficient targeting of anthelmintic treatments and reduce the required frequency of FEC testing. The aim here was to investigate strongyle egg shedding consistency in populations of horses in the UK that followed a targeted anthelmintic treatment program, with a focus on horses identified as low strongyle egg shedders (<50 epg), to examine whether non-treatment of these individuals was associated with increases in egg shedding levels over time. This study also analyzed factors associated with shedding consistency in individuals within these populations. A longitudinal cohort study design was used.
Materials and Methods

Study Population
During 2010-2012, 573 horses from 26 equine holdings (yards) in Scotland and England were recruited (see Supplementary Table 1 ). The number of individual's resident on each yard ranged from 7 to 72 (median, 20 horses). Most horses (i.e., those on 19 yards) received moxidectin prior to the start of the study, although all had received a macrocyclic lactone (ML) within the 6 months prior to the start of the study (n ¼ 573). On three yards, information on which anthelmintic was last administered was not supplied. Most horses were resident at livery yards (n ¼ 23 yards). The remainder comprised of a non-Thoroughbred stud farm, a sport horse yard, and a rescue/welfare sanctuary. In total, 573 horses were screened at S1, 468 horses at S2, and 417 at S3. A total of 83 horses on three yards were screened at S4. Each horse was assigned an age category. The age distribution was as follows: foal (<2 years; n ¼ 26), youngster (!2 and <5 years; n ¼ 68), adult (!5 and <18 years; n ¼ 418), and geriatric (!18 years; n ¼ 61).
All horses included in this study had access to grazing, were at pasture during the study, and had been treated with a ML anthelmintic within the previous 6 months. Horses were at pasture for a minimum of 8 hours per day and were grazed on the same pastures for the duration of the trial (i.e., returned to the same pasture after sampling and treatment). Yards with a minimum of 10 horses were included, and all horses were subject to the same anthelmintic treatment regimen (Section 2.2). Each yard was supplied with a questionnaire to provide information on the demographics (i.e., yard function, number of horses, etc.), anthelmintic usage (frequency of treatment, last product used, type of deworming program followed), and general management practices. Yard managers were asked to supply the age of the horses included in the study but not specific details on breed and sex. On all yards, the manager was the point of contact and was responsible for completion of the questionnaire, coordinating sample collection and postage, and administering anthelmintic treatments.
Targeted Treatment Protocol
Horses that were previously treated with anthelmintic were sampled after a minimum period of 18 weeks had elapsed after administration of moxidectin or 14 weeks for ivermectin. The first sample (screen 1, S1, n ¼ 573) was collected between February and March. Horses with FEC !200 epg were treated with pyrantel embonate following the manufacturer's instructions (Strongid-P paste; Elanco Animal Health, Basingstoke, Hampshire, UK, at a dose rate of 19 mg/kg bodyweight). All horses were FEC screened 8-10 weeks later: This was based on a 6-week strongyle egg reappearance period (ERP) for pyrantel embonate [15, 16] , plus an additional 2 weeks (screen 2, S2; May/June, n ¼ 468). Horses with FEC !200 epg at S2 were treated with ivermectin (Eqvalan oral paste for horses, 0.2 mg/kg; Merial Animal Health, Harlow, Essex, UK). All horses were screened 10-12 weeks later based on an ivermectin strongyle ERP of 8-10 weeks [15] , plus 2 additional weeks (screen 3, S3; August/September, n ¼ 417). At this point, horses with a FEC of !200 epg were treated with moxidectin (Equest Oral Gel, 0.4 mg/kg; Zoetis UK Limited, Tadworth, Surrey, UK). On some yards, a fourth screen (S4; October/December, n ¼ 83) was performed on horses that had not received anthelmintic treatment following S3.
Sample Collection and FEC Methodology
Samples were collected from freshly passed feces and placed into individually labeled zip-lock bags. Yard managers were provided with instructions on how to collect, store, and post the samples and were asked to collect at least three boli from freshly voided feces and to place these into the bag, expelling air before sealing. The samples were sent immediately to the Moredun Research Institute and stored at approximately 4 C. All samples were processed within 4 days of excretion to reduce the effect of egg degradation [17] . A modification of the salt flotation method (1.2 specific gravity) with a detection limit (dl) down to 1 epg was used [18] . All samples were analyzed in duplicate by taking two 10 mL aliquots from a 100-mL dilution of a well-mixed 10-g subsample and an average taken to estimate the epg count.
Data Analysis
Egg Shedding and Anthelmintic Treatment Categories
Each FEC data point on each screening occasion (S1, S2, S3, S4) was assigned a shedding category: 1 (0-49 epg); 2 (50-99 epg); 3 (100-199 epg); 4 (200-299 epg); 5 (300-399 epg); 6 (400-499 epg); and 7 (>500 epg). Each FEC data point was also assigned a treatment category: <200 epg (0, no treatment) or !200 epg (1, treatment).
Egg Shedding Consistency
To assess shedding consistency, the rank change in shedding category between S1 and S2, S1 and S3, and S1 and S4 was calculated. For example, if the category was ranked as 1 for S1 and 6 for S2, the rank change would be 5. Conversely, if the category was measured as 6 for S1 and 3 for S3, the rank change would be À3. If the category remained the same, rank change assigned was 0.
Anthelmintic Treatment Consistency
Treatment category consistency was determined across S1 and S2, S1 and S3, and S1 and S4. If an individual's FEC changed from <200 epg to !200 epg between two sampling points, the rank assigned was 1. If it changed from !200 epg to <200 epg, it was assigned as À1, and if it remained above or below the 200 epg threshold, it was assigned 0.
Egg Shedding and Treatment Consistency Analysis
For each sampling occasion, the number and percentage of horses in each shedding and treatment category were calculated. Furthermore, the number and percentage of horses that were in each rank change category of shedding (À6 to 6) and treatment (À1, 0, or 1) between S1 and each subsequent screening occasion was calculated. To test if there was a significant difference (P < .05) in the proportion of horses falling into each shedding and treatment category between screening occasions, a binomial test was performed using the prop.test function in RStudio. All analyses were performed in RStudio, version 2.15.1 (The R Foundation for Statistical Computing, 2012). The analysis that was applied to the anthelmintic-treated horses was applied to horses that had not received anthelmintic during the study to assess if no treatment was associated with lower shedding consistency and rising FEC over time. All horses included in this analysis had FEC <200 epg at S1.
Factors Affecting Egg Shedding and Anthelmintic Treatment Consistency
The effect of age, last anthelmintic administered, and number of weeks after the expected ERP of each anthelmintic on the likelihood of a horse changing shedding or treatment category between S1 and S3 was assessed using multivariable logistic regression. Factors included in the initial model are shown in Table 1 . Regression analysis was performed using the GLM function in R (RStudio, version 2.15.1), specifying the family as binomial, linked to logit transformation, g, where P is the probability of a horse changing shedding or treatment category, b i is the model (slope) coefficient, and X i is the explanatory variable (Equation 1).
The probability of a change in egg shedding and treatment category was estimated using Equation 2.
Regression models were initially populated with all potential explanatory variables (age category, last treatment, time in weeks since expected ERP elapsed, Table 1 ), then variables with the highest, nonsignificant P-values removed in a stepwise process until a model with only significant terms remained. The effect of removing factors from the model was evaluated using log-likelihood ratio tests [19, 20] . P-values (Wald) of .05 indicated factors that had a significant influence on changing shedding or treatment category in the final model. The Hosmer-Lemeshow test [21] was used to assess overall model fit using the "ResourceSelection" package [22] .
Results
Consistency of Strongyle Egg Shedding and Treatment With Anthelmintic
At S1, 70.0% (401/573) of horses were shedding less than 50 epg (Fig. 1A) . This level of shedding was not significantly different at S2 (65.0%, 304/468) and S3 (66.2%, 276/417), with the proportions in shedding categories 2 and 3 also not significantly different compared to S1. The percentage of horses in category 7 was low compared to the percentage of horses in category 1: for example, 5.8% (33/573) at S1 and 0.0% (0/83) at S4. On each occasion, the percentage of horses in the "no treatment" category ranged from 83.6% (479/573) at S1 to 91.6% (76/83) at S4 (Fig. 1B) .
Egg Shedding and Treatment Consistency
Most horses remained in the same egg shedding and treatment category over time ( Fig. 2A) . From S1 to S2, 61.5% horses (288/468) remained in the same shedding category, from S1 to S3, 58.3% (243/417), and from S1 to S4, 73.5% (61/ 83). Between S1 and S2, 16.6% (77/468) horses moved to a lower shedding category and 22.0% (103/468) to a higher shedding category. Between S1 and S3, 23.7% (99/417) moved into a lower shedding category and 18.0% (75/417) moved into a higher shedding category. Between S1 and S4, 14.5% (12/83) horses moved into a lower shedding category and 8.3% (10/83) individuals moved to a higher shedding category. Between S1 and S2, S1 and S3, and S1 and S4, 81.8% (383/468), 82.7% (345/417), and 94.0% (78/83) horses remained in the same treatment category, respectively (Fig. 2B) . The egg shedding consistency in a subgroup that did not receive anthelmintic during the entire study (n ¼ 304) was investigated. The proportion of horses shedding <50 epg at S1 was 97.3% (296/304); at S2, 84.9% (258/304); and at S3, 85.5% (213/249). The change in proportion of horses shedding <50 epg was consistent throughout the study (P > .05). Between S1 and S2, 92.1% (280/304) horses remained in the same shedding category, 0.3% (1/304) were in a lower shedding category, and 7.9% (23/304) in a higher shedding category. Between S1 and S3, the percentage of horses that remained in the same shedding category was 90.4% (225/304), and the percentage of horses that were in a higher shedding category was 9.6% (24/304).
Factors Associated With Changing Strongyle Egg Shedding Category or Treatment Category Over Time
Only horses (n ¼ 346) for which information on age and last anthelmintic treatment was available were included in were also investigated (model 2). In the final model (Table 2) , young horses (!2 to <5 years) were more likely to change treatment category compared to foals (<2 years), adult horses (!5 to <18 years), and geriatric horses (!18 years, OR ¼ 2.8; 95% CI ¼ 1.1-6.3; P ¼ .03), and horses that received moxidectin as their last treatment were significantly less likely to change treatment group compared to horses that received ivermectin or pyrantel (OR ¼ 0.15; 95% CI ¼ 0.1-0.4; P < .0001). 2 . The rank change in egg shedding category and treatment category between sampling occasions (S1 and S2, S1 and S3, and S1 and S4). The percentage of horses remained in the same egg shedding category (0), increased egg shedding category (1-6), or decreased egg shedding category (À1 to À6), with a rank change in À6 categories represented by the darkest shade of gray and subsequent ascending categories in lighter shades (A). The percentage of horses that remained in the same treatment category (0, mid-gray), increased in treatment category (1, light gray), or decreased in treatment category (À1, dark gray) (B) as measured by fecal egg count (FEC) on each screening occasion. The width of the bars is proportional to the number of observations per screening occasion. There were no statistical differences (P < .05) in proportions between screening occasions as determined by the binomial test.
Discussion
Knowledge that horses shed strongyle eggs at consistent levels over time can help underpin evidence-based targeted treatment control programs [23] . Currently, FEC-directed targeted treatment programs are recommended for adult horses, whereby individuals are screened for strongyle egg shedding every 4-6 weeks during the grazing season and those excreting !200 epg treated with anthelmintic [10] . Here, strongyle egg shedding in horses, analyzed over three to four sampling occasions within a grazing season, was found to be consistent. These results agree with those of previous studies which sampled horses over longer periods (1-3 years) [12] [13] [14] and shorter periods [11] . Each of these studies reported a high level of shedding consistency in horses sampled from the general population. One study reported that, if the first two FECs were 0 epg, there was an 82% probability that the third FEC would be 0 epg and a 91% chance that it would be < 200 epg. Additionally, these authors found that if the first two counts were <200 epg, there was an 84% chance that the next FEC would be <200 epg, and if the first two FECs were !200 epg, there was a 59% probability that the next FEC would be !200 epg [12] . This latter study demonstrated that egg shedding was consistent over a longer sampling period compared to that of the current one, particularly in horses that were measured as shedding 0 epg at the start. In a later survey [13] , which followed a similar sampling time frame to ours, horses were treated with anthelmintic when the FEC was measured as !250 epg and only data from horses that did not receive anthelmintic were analyzed. The authors reported that if the first two FECs were 0 epg, there was a 62% probability that the maximum FEC of the next seven samples would be 0 epg, and if the first two FECs were 0 epg, there was an 88% probability that the maximum FEC of the next seven counts would be <200 epg. The authors concluded that, for individual horses, the magnitude of the initial FEC was significantly positively correlated to the maximal FEC of the subsequent eight counts [13] . In a further study, the repeatability of strongyle egg counts was assessed in naturally infected horses [14] . In that study, samples were collected over 9 consecutive months and analyzed using a McMaster method with an egg count dl of 20 epg. These authors defined repeatability as the variance between horses divided by the total variance, meaning that a value of 0 indicates no consistency in FEC and a value of 1 indicates perfect consistency. Using raw egg counts (i.e., the number of actual eggs counted before applying the multiplication factor), the within-horse repeatability was 0.52 in all horses and 0.53 when horses that had received treatment were excluded from the analysis [14] . Despite each of the studies described following different counting methodology and distinctive statistical analyses, all demonstrate that strongyle egg shedding in horses was consistent over short and longer sampling time frames, especially in low egg shedding categories, indicating that such horses tend to excrete low numbers of eggs in the absence of anthelmintic treatment, over a prolonged period. In contrast to these reports, one study examined strongyle egg shedding consistency in ponies managed for conservation purposes, which remained largely untreated with anthelmintic over several years and found that shedding consistency at individual level was generally weak [7] . In that study, FEC data were analyzed using general additive mixed models to estimate repeatability of FEC at individual level and to test for differences in mean FEC among populations and age classes. Climate and season were found to exert a significant effect on FECs measured in individuals in populations that did not receive anthelmintic, and a strong interaction was identified between age and climate. The lack of individual consistency observed by Wood et al (2013) compared with other studies [11] [12] [13] [14] could be due to the length of time over which the data were collected, the FEC method used, the absence of anthelmintic treatments, the type of statistical analysis undertaken, or the nature of and level of exposure to parasite infection.
Past studies investigating strongyle egg shedding consistency focused on estimates of strongyle FEC using McMaster methods with egg dls between 20 and 50 epg [7, [11] [12] [13] [14] . In the current study, a more sensitive count method was used. Fecal egg count generated using McMaster methods tends to generate higher epg estimates and greater variance. In addition, using a FEC method with a higher egg dl (i.e., multiplication factor), the methodology will be less sensitive to relatively small changes in egg abundance, and larger multiplication factors will artificially inflate variance [6, 24] . This may potentially lead to lower observed consistency between egg counts from the same individual over time because of the greater degree of artifactual variation in FEC. On the other hand, the higher number of false negative FEC arising from the limited dl of Abbreviations: LRT, likelihood ratio test; MOX, moxidectin; Na, not applicable. For each significant variable, the logit coefficient, the standard error (SE), the odds ratio (OR) and associated 95% confidence intervals (CIs), and the significance (P < .05) are presented. a Model fit was assessed using the Hosmer and Lemeshow test.
traditional McMaster methods could artificially increase apparent consistency of 0 measured epg over time in lowshedding horses. In the present study, measures were taken to ensure samples were collected, stored, and processed in a way to minimize egg degradation [17] , to ensure that a representative sample was collected to reduce egg clumping in feces [10] , and to minimize the effects of rounding error by using a very sensitive FEC method. However, the way in which the samples were collected and handled on each yard on each sampling occasion could have impacted the consistency of the results. Here, egg shedding consistency was higher in adult and geriatric horses compared to youngsters. This lower level of consistency in FEC shedding in younger horses could be related to lower immunity [25] compared with older horses, such that variation in parasite challenge is less buffered and feeds through to downstream variation in FEC.
In the current study, horses that were treated with moxidectin prior to the start of the study were less likely to change shedding or treatment category compared to those that had been treated with ivermectin or pyrantel. A likely reason for this is that shedding would be lower in horses previously treated with moxidectin due to its persistent effect against parasites in vivo [26] . Moxidectin has an elimination half-life of 23.11 days compared to ivermectin (4.25 days) and pyrantel (13.43 hours) [26] . This means that parasites are exposed to active anthelmintic for longer periods; hence, the greater strongyle ERP observed after moxidectin treatment [26] . Moxidectin exhibits higher larvicidal activity compared to the other two anthelmintics, particularly against mucosal larvae [26] [27] [28] . This will also affect the strongyle ERP observed after moxidectin administration compared to other equine anthelmintics [26, 29] .
Recruitment of yards was nonrandom, being through veterinary practices and the BHS website. Nevertheless, there was heterogeneity in the yards recruited, which is likely to have provided a fairly representative sample of the UK equine population, outside breeding establishments, which have a younger age profile [6] . As such, further research is required to assess consistency of strongyle egg shedding in populations on breeding farms.
It should be noted that the FEC data collected here were obtained over a single grazing season, and the effect of season and climate were not accounted for, both of which can impact strongyle egg shedding patterns [7] . Furthermore, the effects of management practices such as removal of feces from pasture were not investigated, which has been shown to significantly reduce FEC in donkeys that grazed pasture where dung was removed twice weekly by reducing larval populations on pasture [30] . Long-term studies investigating strongyle egg shedding patterns taking account of season, climate, and management practices are warranted as these factors impact the intensity of larval contamination on pasture, which will in turn affect the egg shedding intensity downstream. This will help to better inform FEC-directed targeted anthelmintic treatment programs and to understand the appropriate frequency of FEC testing.
In conclusion, egg shedding and treatment status at individual level were found to be relatively consistent, especially in adult horses, regardless of whether or not they had been treated with anthelmintic, indicating that horses with negative or low FEC (<50 epg) initially were significantly more likely to have low FEC on subsequent occasions, and horses with a high FEC (!200 epg) were significantly more likely to have a high FEC on subsequent occasions. Furthermore, an adult horse not requiring anthelmintic treatment initially (based on a 200 epg threshold) would be less likely to require treatment on subsequent occasions in that season. These findings would suggest that the majority of adult horses are able to regulate their strongyle burden, leading to a maintained low FEC status. There is a lack of published information on long-term patterns of strongyle egg shedding in equine populations, especially in horses managed under FECdirected anthelmintic treatment programs; this should be assessed in future, particularly in horses that are not receiving regular anthelmintic treatments.
